November 22, 2011
At a meeting on November 22, the Council for Hepatitis Treatment Strategy (chairperson: Norio Hayashi, director of Kansai Rosai Hospital) recommended subsidizing the three-drug combination therapy for chronic hepatitis C using peginterferon, ribavirin, and telaprevir. Patients with HCV-RNA-positive hepatitis C...read more